Trial NCT04071236

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2019-05620
Secondary IDs: 10301 202006062 NCI-2019-05620 UM1CA186689 UM1CA186704

Last trial update was posted on 2024-02-05

MeSH Interventions

Antibodies, Monoclonal Avelumab Peposertib Radium Ra 223 dichloride

MeSH Conditions

Carcinoma Neoplasms Prostatic Neoplasms

Other Conditions

Castration-Resistant Prostate Carcinoma Metastatic Malignant Neoplasm in the Lymph Nodes Metastatic Prostate Carcinoma Stage IV Prostate Cancer AJCC v8

Stopping Reasons

End of Initial Phase of Multi-phase protocol

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID